We found TP53 mutations in the intron of the gene which have been found to alter TP53 protein expression through several mechanisms such as aberrant pre-messenger mRNA splicing and disruption of DNA-transcription factor interactions in a variety of cancer types, as well as, single nucleotide polymorphism in introns associated with higher cancer risk [27–29]. Here, TP53 is linked to cancer.